Seroprevalence and molecular characterization of Toxoplasma gondii among patients at the Pasteur Institute of Cte dIvoire
Journal of Parasitology and Vector Biology · 2025
DOI: 10.5897/jpvb2025.0456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parasitology and Vector Biology, 2025. Verfasst von A. H. Bosson-Vanga und 18 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Toxoplasmosis, a zoonosis caused by Toxoplasma gondii, represents an emerging threat to global public health. Serological tests are the primary methods for the routine diagnosis of toxoplasmosis. Tests may fail to detect specific anti-toxoplasma antibodies during the early phase of the infection and during T. gondii infection in immuno-compromised patients. This is why it is useful to combine serology with molecular detection of T. gondii. Thus, this study aimed to perform molecular detection of T. gondii on seropositive patients for toxoplasma serology at the Institute Pasteur of Côte d’Ivoire. Following serology, molecular detection with DNA extraction from whole blood and polymerase chain reaction (PCR) was performed in seropositive patients. Out of the 323 enrolled patients, 162 (50.15%) showed IgG antibodies against T. gondii; 11 of them (3.40%) had both IgG and IgM. No patients were found with exclusive IgM antibodies. No parasite DNA was detected in their blood samples. A bivariate analysis did not indicate an association between seropositivity to T. gondii and variables of interest. The prevalence of T. gondii infection suggests significant exposure to the parasite. Seroprevalence was not significantly associated with sex or age. According to this study’s knowledge, it is the first study to detect T. gondii DNA in Côte d’Ivoire, which unfortunately was not detected. T. gondii should not be underestimated because negative results indicate the absence of detectable DNA but do not exclude the presence of the organism or active or recent disease. Key words: Toxoplasmosis, Toxoplasma gondii, seroprevalence, molecular diagnosis, Côte d’Ivoire.
Zitieren
APA
Bosson-Vanga, A. H., Essy, K. J., Bonouman-Ira, A. V., Miezan, A. J. S., Koné, F., Kouman, K. B. A., Tuo, K., Aka, T. C., N’docho, A. F. T., Yapo, V., Koné, E. G. M., Konaté-Touré, A., Angora, K. E., Bedia-Tanoh, A. V., Kiki-Barro, P. C. M., Kassi, K. F., Yavo, W., Menan, E. I. H., & Touré, O. A. (2025). Seroprevalence and molecular characterization of Toxoplasma gondii among patients at the Pasteur Institute of Cte dIvoire. Journal of Parasitology and Vector Biology. https://doi.org/10.5897/jpvb2025.0456
Vancouver
Bosson-Vanga AH, Essy KJ, Bonouman-Ira AV, Miezan AJS, Koné F, Kouman KBA, et al. Seroprevalence and molecular characterization of Toxoplasma gondii among patients at the Pasteur Institute of Cte dIvoire. Journal of Parasitology and Vector Biology. 2025. doi:10.5897/jpvb2025.0456
BibTeX
@article{BossonVanga2025,
author = {Bosson-Vanga, A. H. and Essy, K. J. and Bonouman-Ira, A. V. and Miezan, A. J. S. and Koné, F and Kouman, K. B. A. and Tuo, K. and Aka, T. C. and N’docho, A. F. T. and Yapo, V. and Koné, E. G. M. and Konaté-Touré, A. and Angora, K. E. and Bedia-Tanoh, A. V. and Kiki-Barro, P. C. M. and Kassi, K. F. and Yavo, W. and Menan, E. I. H. and Touré, O. A.},
title = {Seroprevalence and molecular characterization of Toxoplasma gondii among patients at the Pasteur Institute of Cte dIvoire},
journal = {Journal of Parasitology and Vector Biology},
year = {2025},
doi = {10.5897/jpvb2025.0456}
}
EUVIMED